BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35801577)

  • 1. Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma.
    Di Rocco A; Camero S; Benedetti A; Lozanoska-Ochser B; Megiorni F; Marchese C; Stramucci L; Ciccarelli C; Bouché M; Bossi G; Marampon F; Zani BM
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35801577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma.
    Marampon F; Bossi G; Ciccarelli C; Di Rocco A; Sacchi A; Pestell RG; Zani BM
    Mol Cancer Ther; 2009 Mar; 8(3):543-51. PubMed ID: 19258428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population.
    Ciccarelli C; Vulcano F; Milazzo L; Gravina GL; Marampon F; Macioce G; Giampaolo A; Tombolini V; Di Paolo V; Hassan HJ; Zani BM
    Mol Cancer; 2016 Feb; 15():16. PubMed ID: 26897742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence.
    Wang W; Chen JX; Liao R; Deng Q; Zhou JJ; Huang S; Sun P
    Mol Cell Biol; 2002 May; 22(10):3389-403. PubMed ID: 11971971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
    Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G
    Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells.
    Mauro A; Ciccarelli C; De Cesaris P; Scoglio A; Bouché M; Molinaro M; Aquino A; Zani BM
    J Cell Sci; 2002 Sep; 115(Pt 18):3587-99. PubMed ID: 12186945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.
    Megiorni F; Gravina GL; Camero S; Ceccarelli S; Del Fattore A; Desiderio V; Papaccio F; McDowell HP; Shukla R; Pizzuti A; Beirinckx F; Pujuguet P; Saniere L; der Aar EV; Maggio R; De Felice F; Marchese C; Dominici C; Tombolini V; Festuccia C; Marampon F
    J Hematol Oncol; 2017 Oct; 10(1):161. PubMed ID: 28985758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals.
    Marampon F; Gravina GL; Di Rocco A; Bonfili P; Di Staso M; Fardella C; Polidoro L; Ciccarelli C; Festuccia C; Popov VM; Pestell RG; Tombolini V; Zani BM
    Mol Cancer Ther; 2011 Jan; 10(1):159-68. PubMed ID: 21220498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
    Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C
    Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade.
    Yamauchi J; Tsujimoto G; Kaziro Y; Itoh H
    J Biol Chem; 2001 Jun; 276(26):23362-72. PubMed ID: 11304531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation.
    Cong F; Goff SP
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13819-24. PubMed ID: 10570156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha.
    Suzuki K; Hino M; Hato F; Tatsumi N; Kitagawa S
    Blood; 1999 Jan; 93(1):341-9. PubMed ID: 9864179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression.
    Fujishiro M; Gotoh Y; Katagiri H; Sakoda H; Ogihara T; Anai M; Onishi Y; Ono H; Funaki M; Inukai K; Fukushima Y; Kikuchi M; Oka Y; Asano T
    J Biol Chem; 2001 Jun; 276(23):19800-6. PubMed ID: 11279172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells.
    Shin I; Kim S; Song H; Kim HR; Moon A
    J Biol Chem; 2005 Apr; 280(15):14675-83. PubMed ID: 15677464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells.
    Huot M; Caron M; Richer C; Djibo R; Najmanovich R; St-Onge P; Sinnett D; Raynal NJM
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):845-856. PubMed ID: 34331108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis.
    Tanaka N; Kamanaka M; Enslen H; Dong C; Wysk M; Davis RJ; Flavell RA
    EMBO Rep; 2002 Aug; 3(8):785-91. PubMed ID: 12151339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis.
    Engelman JA; Berg AH; Lewis RY; Lin A; Lisanti MP; Scherer PE
    J Biol Chem; 1999 Dec; 274(50):35630-8. PubMed ID: 10585441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases.
    Deacon K; Blank JL
    J Biol Chem; 1999 Jun; 274(23):16604-10. PubMed ID: 10347227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.